title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Wednesday,20220511T162815,https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article,INO,0.006905,Neutral,-0.000746
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,INO,0.00644,Bearish,-0.361636
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,INO,0.005366,Neutral,0.021183
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,INO,0.013173,Neutral,0.040164
Clusters of monkeypox cases are driving up stock prices for some companies,20220523T195300,https://www.marketwatch.com/story/clusters-of-monkeypox-cases-are-driving-up-stock-prices-for-some-companies-11653335587,INO,0.092337,Neutral,-0.12754
24 Stocks Moving in Monday's Pre-Market Session,20220523T101343,https://www.benzinga.com/news/22/05/27342423/24-stocks-moving-in-mondays-pre-market-session,INO,0.152741,Neutral,0.000412
6 Stocks To Watch Amid Monkeypox Outbreak,20220520T210817,https://www.benzinga.com/news/22/05/27334070/6-stocks-to-watch-amid-monkeypox-outbreak,INO,0.142904,Neutral,0.000326
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,INO,0.02074,Neutral,-0.002722
99 Biggest Movers From Yesterday,20220512T082956,https://www.benzinga.com/news/22/05/27156577/99-biggest-movers-from-yesterday,INO,0.042462,Bearish,-0.698075
"Earnings Scheduled For May 10, 2022",20220510T091808,https://www.benzinga.com/news/earnings/22/05/27099859/earnings-scheduled-for-may-10-2022,INO,0.015162,Neutral,-0.008384
Stocks That Hit 52-Week Lows On Friday,20220610T154524,https://www.benzinga.com/markets/options/22/06/27650434/52-weeks-high-and-low-article,INO,0.013393,Neutral,0.000356
